Senti Biosciences Holdings, Inc.
SNTI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001854270
No open-market purchases or sales by Senti Biosciences Holdings, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $6.37M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Senti Biosciences Holdings, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +3 vs. Q2 2022
- Shares held
- 13.5M
- +1.56M (+13.1%) vs. Q2 2022
- Total value
- $27.8M
- +$5.75M (+26.1%) vs. Q2 2022
- New holders
- 7
- 8 more added
- Sold out
- 4
- 1 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SNTI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $6.37M |
| Q1 2026 | 16 | $4.58M |
| Q4 2025 | 15 | $5.84M |
| Q3 2025 | 16 | $8.27M |
| Q2 2025 | 15 | $14.2M |
| Q1 2025 | 16 | $19.9M |
| Q4 2024 | 16 | $3.23M |
| Q3 2024 | 14 | $2.41M |
| Q2 2024 | 20 | $2.17M |
| Q1 2024 | 27 | $4.15M |
| Q4 2023 | 25 | $7.56M |
| Q3 2023 | 26 | $5.02M |
| Q2 2023 | 28 | $7.64M |
| Q1 2023 | 24 | $14.3M |
| Q4 2022 | 26 | $16.6M |
| Q3 2022 | 23 | $27.8M |
| Q2 2022 | 20 | $22.1M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Senti Biosciences Holdings, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wolverine Asset Management LLC | 800 | $1.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 2,388 | $5.00K | 0.00% | +2,388 | New |
| BlackRock Inc. | 2,628 | $6.00K | 0.00% | +2,628 | New |
| FNY Investment Advisers, LLC | 3,500 | $7.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 9,452 | $21.0K | 0.00% | +8,224+669.7% | Added |
| UBS Group AG | 9,647 | $21.0K | 0.00% | +9,637+96,370.0% | Added |
| Bank of America Corp | 14,316 | $31.0K | 0.00% | +11+0.1% | Added |
| Northern Trust Corp | 14,296 | $31.0K | 0.00% | +14,296 | New |
| Allen Operations LLC | 21,443 | $47.0K | 0.01% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 25,000 | $54.0K | 0.00% | +25,000 | New |
| Millennium Management LLC | 43,689 | $95.0K | 0.00% | +7,467+20.6% | Added |
| Hongkou Capital LP | 56,454 | $123.0K | 0.30% | +56,454 | New |
| Kingfisher Capital LLC | 114,224 | $248.0K | 0.07% | +1,061+0.9% | Added |
| Manufacturers Life Insurance Company, The | 117,707 | $248.4K | 0.00% | +117,707 | New |
| TD Asset Management Inc | 134,892 | $285.0K | 0.00% | +47,196+53.8% | Added |
| Geode Capital Management, LLC | 167,275 | $362.0K | 0.00% | +139,152+494.8% | Added |
| Omega Fund Management, LLC | 195,792 | $425.0K | 0.16% | 00.0% | Unchanged |
| Morgan Stanley | 350,414 | $760.0K | 0.00% | −599,444−63.1% | Reduced |
| Intel Corp | 595,665 | $1.29M | 0.52% | 00.0% | Unchanged |
| Artal Group S.A. | 1,055,555 | $2.29M | 0.12% | 00.0% | Unchanged |
| ARK Investment Management LLCSuperinvestorARK Invest | 2,087,696 | $4.53M | 0.03% | +2,087,696 | New |
| NEA Management Company, LLC | 4,429,725 | $8.23M | 0.41% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 4,015,483 | $8.71M | 0.00% | +425,898+11.9% | Added |
| Caas Capital Management LP | 0 | $0 | 0.00% | −756,678−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −22,025−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −2,275−100.0% | Sold out |
| Clear Street LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |